Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Early MRI predictors of disease-free survival in locally advanced rectal cancer from the GRECCAR 4 trial.

Nougaret S, Castan F, de Forges H, Vargas HA, Gallix B, Gourgou S, Rouanet P; GRECCAR Study Group.

Br J Surg. 2019 Aug 22. doi: 10.1002/bjs.11233. [Epub ahead of print]

PMID:
31436325
2.

Imaging of Testicular and Scrotal Masses: The Essentials.

Wibmer AG, Vargas HA.

In: Hodler J, Kubik-Huch RA, von Schulthess GK, editors. Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book [Internet]. Cham (CH): Springer; 2018. Chapter 24.
2018 Mar 21.

3.

MRI of Tumors and Tumor Mimics in the Female Pelvis: Anatomic Pelvic Space-based Approach.

Nougaret S, Nikolovski I, Paroder V, Vargas HA, Sala E, Carrere S, Tetreau R, Hoeffel C, Forstner R, Lakhman Y.

Radiographics. 2019 Jul-Aug;39(4):1205-1229. doi: 10.1148/rg.2019180173.

PMID:
31283453
4.

Comparison of Motion-Insensitive T2-Weighted MRI Pulse Sequences for Visualization of the Prostatic Urethra During MR Simulation.

Zakian KL, Wibmer A, Vargas HA, Alberts E, Kadbi M, Mychalczak B, Kollmeier M, Gorovets D, McBride S, Hunt M, Zelefsky MJ, Tyagi N.

Pract Radiat Oncol. 2019 Jun 25. pii: S1879-8500(19)30180-8. doi: 10.1016/j.prro.2019.06.009. [Epub ahead of print]

PMID:
31252087
5.

Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.

Perez-Lopez R, Tunariu N, Padhani AR, Oyen WJG, Fanti S, Vargas HA, Omlin A, Morris MJ, de Bono J, Koh DM.

Radiology. 2019 Aug;292(2):273-286. doi: 10.1148/radiol.2019181931. Epub 2019 Jun 25.

PMID:
31237493
6.

Contribution of Radiology to Staging of Prostate Cancer.

Woo S, Ghafoor S, Vargas HA.

Semin Nucl Med. 2019 Jul;49(4):294-301. doi: 10.1053/j.semnuclmed.2019.02.007. Epub 2019 Mar 9. Review.

PMID:
31227052
7.

Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Woo S, Suh CH, Eastham JA, Zelefsky MJ, Morris MJ, Abida W, Scher HI, Sidlow R, Becker AS, Wibmer AG, Hricak H, Vargas HA.

Eur Urol Oncol. 2019 Jun 13. pii: S2588-9311(19)30071-9. doi: 10.1016/j.euo.2019.05.004. [Epub ahead of print] Review.

PMID:
31204311
8.

Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?

Viana PCC, Horvat N, do Santos VR Júnior, Lima TC, Romão DDS, Cerri LMO, de Castro MG, Vargas HA, Miranda JA, Leite CDC, Cerri GG.

Int Braz J Urol. 2019 Jul-Aug;45(4):724-731. doi: 10.1590/S1677-5538.IBJU.2018.0382.

9.

The Diagnostic Performance of MRI for Detection of Extramural Venous Invasion in Colorectal Cancer: A Systematic Review and Meta-Analysis of the Literature.

Kim TH, Woo S, Han S, Suh CH, Vargas HA.

AJR Am J Roentgenol. 2019 Sep;213(3):575-585. doi: 10.2214/AJR.19.21112. Epub 2019 May 7.

PMID:
31063424
10.

Contemporary Management of Hemorrhage After Minimally Invasive Radical Prostatectomy.

Dean LW, Tin AL, Chesnut GT, Assel M, LaDuke E, Fromkin J, Vargas HA, Ehdaie B, Coleman JA, Touijer K, Eastham JA, Laudone VP.

Urology. 2019 Aug;130:120-125. doi: 10.1016/j.urology.2019.04.021. Epub 2019 Apr 26.

PMID:
31034916
11.

Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancer.

Wibmer AG, Robertson NL, Hricak H, Zheng J, Capanu M, Stone S, Ehdaie B, Brawer MK, Vargas HA.

Abdom Radiol (NY). 2019 Aug;44(8):2864-2873. doi: 10.1007/s00261-019-02023-1.

PMID:
31030245
12.

Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.

Kramer GM, Yaqub M, Vargas HA, Schuit R, Windhorst AD, van den Eertwegh A, van der Veldt A, Bergman A, Burnazi E, Lewis JS, Chua SS, Staton K, Beattie BJ, Humm JL, Davis ID, Weickhardt A, Scott A, Morris MJ, Hoekstra OS, Lammertsma AA.

J Nucl Med. 2019 Mar 8. pii: jnumed.118.220111. doi: 10.2967/jnumed.118.220111. [Epub ahead of print]

PMID:
30850488
13.

How clinical imaging can assess cancer biology.

García-Figueiras R, Baleato-González S, Padhani AR, Luna-Alcalá A, Vallejo-Casas JA, Sala E, Vilanova JC, Koh DM, Herranz-Carnero M, Vargas HA.

Insights Imaging. 2019 Mar 4;10(1):28. doi: 10.1186/s13244-019-0703-0. Review.

14.

Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone.

Jansen BHE, Kramer GM, Cysouw MCF, Yaqub MM, de Keizer B, Lavalaye J, Booij J, Vargas HA, Morris MJ, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE.

J Nucl Med. 2019 Aug;60(8):1111-1117. doi: 10.2967/jnumed.118.222505. Epub 2019 Jan 10.

PMID:
30630941
15.

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.

Abida W, Cheng ML, Armenia J, Middha S, Autio KA, Vargas HA, Rathkopf D, Morris MJ, Danila DC, Slovin SF, Carbone E, Barnett ES, Hullings M, Hechtman JF, Zehir A, Shia J, Jonsson P, Stadler ZK, Srinivasan P, Laudone VP, Reuter V, Wolchok JD, Socci ND, Taylor BS, Berger MF, Kantoff PW, Sawyers CL, Schultz N, Solit DB, Gopalan A, Scher HI.

JAMA Oncol. 2019 Apr 1;5(4):471-478. doi: 10.1001/jamaoncol.2018.5801.

PMID:
30589920
16.

Ovarian cancer: An update on imaging in the era of radiomics.

Nougaret S, Tardieu M, Vargas HA, Reinhold C, Vande Perre S, Bonanno N, Sala E, Thomassin-Naggara I.

Diagn Interv Imaging. 2018 Dec 13. pii: S2211-5684(18)30295-X. doi: 10.1016/j.diii.2018.11.007. [Epub ahead of print]

PMID:
30555018
17.

Isolation on a remote island: genetic and morphological differentiation of a cosmopolitan odonate.

Alvial IE, Vargas HA, Marinov M, Esquivel C, Araya J, Araya-Donoso R, Vila I, Véliz D.

Heredity (Edinb). 2019 Jun;122(6):893-905. doi: 10.1038/s41437-018-0165-z. Epub 2018 Dec 12.

PMID:
30542146
18.

Consensus on molecular imaging and theranostics in prostate cancer.

Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, De Bono J, Fizazi K, Gillessen S, Gledhill S, Haberkorn U, Herrmann K, Hicks RJ, Lecouvet F, Montironi R, Ost P, O'Sullivan JM, Padhani AR, Schalken JA, Scher HI, Tombal B, van Moorselaar RJA, Van Poppel H, Vargas HA, Walz J, Weber WA, Wester HJ, Oyen WJG.

Lancet Oncol. 2018 Dec;19(12):e696-e708. doi: 10.1016/S1470-2045(18)30604-1.

PMID:
30507436
19.

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.

Bodo S, Campagne C, Thin TH, Higginson DS, Vargas HA, Hua G, Fuller JD, Ackerstaff E, Russell J, Zhang Z, Klingler S, Cho H, Kaag MG, Mazaheri Y, Rimner A, Manova-Todorova K, Epel B, Zatcky J, Cleary CR, Rao SS, Yamada Y, Zelefsky MJ, Halpern HJ, Koutcher JA, Cordon-Cardo C, Greco C, Haimovitz-Friedman A, Sala E, Powell SN, Kolesnick R, Fuks Z.

J Clin Invest. 2019 Feb 1;129(2):786-801. doi: 10.1172/JCI97631. Epub 2019 Jan 14.

20.

Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer.

Meier A, Veeraraghavan H, Nougaret S, Lakhman Y, Sosa R, Soslow RA, Sutton EJ, Hricak H, Sala E, Vargas HA.

Abdom Radiol (NY). 2019 Jun;44(6):2040-2047. doi: 10.1007/s00261-018-1840-5.

PMID:
30474722
21.

ACR Appropriateness Criteria® Postmenopausal Subacute or Chronic Pelvic Pain.

Expert Panel on Women’s Imaging:, Maturen KE, Akin EA, Dassel M, Deshmukh SP, Dudiak KM, Henrichsen TL, Learman LA, Oliver ER, Poder L, Sadowski EA, Vargas HA, Weber TM, Winter T, Glanc P.

J Am Coll Radiol. 2018 Nov;15(11S):S365-S372. doi: 10.1016/j.jacr.2018.09.023.

PMID:
30392605
22.

Morphology of the immature stages and notes on the natural history of the little-known plume moth Stenoptilodes juanfernandicus Gielis (Lepidoptera: Pterophoridae).

Espinoza-Donoso S, Parra LE, GonzÁlez-Espinoza C, Vargas-Ortiz M, Vargas HA.

Zootaxa. 2018 Aug 28;4462(3):415-425. doi: 10.11646/zootaxa.4462.3.7.

PMID:
30314036
23.

Value of MRI in medicine: More than just another test?

van Beek EJR, Kuhl C, Anzai Y, Desmond P, Ehman RL, Gong Q, Gold G, Gulani V, Hall-Craggs M, Leiner T, Lim CCT, Pipe JG, Reeder S, Reinhold C, Smits M, Sodickson DK, Tempany C, Vargas HA, Wang M.

J Magn Reson Imaging. 2019 Jun;49(7):e14-e25. doi: 10.1002/jmri.26211. Epub 2018 Aug 25.

PMID:
30145852
24.

Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience.

Murray KS, Spaliviero M, Tonorezos ES, Lacouture ME, Tap WD, Oeffinger KC, Vargas HA, Eastham JA.

Urology. 2018 Sep;119:55-61. doi: 10.1016/j.urology.2018.06.008. Epub 2018 Jun 21.

PMID:
29935265
25.

Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, Huddart R, Kennish S, Lerner S, Montironi R, Muglia VF, Salomon G, Thomas S, Vargas HA, Witjes JA, Takeuchi M, Barentsz J, Catto JWF.

Eur Urol. 2018 Sep;74(3):294-306. doi: 10.1016/j.eururo.2018.04.029. Epub 2018 May 10. Review.

PMID:
29755006
26.

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

Iyer G, Balar AV, Milowsky MI, Bochner BH, Dalbagni G, Donat SM, Herr HW, Huang WC, Taneja SS, Woods M, Ostrovnaya I, Al-Ahmadie H, Arcila ME, Riches JC, Meier A, Bourque C, Shady M, Won H, Rose TL, Kim WY, Kania BE, Boyd ME, Cipolla CK, Regazzi AM, Delbeau D, McCoy AS, Vargas HA, Berger MF, Solit DB, Rosenberg JE, Bajorin DF.

J Clin Oncol. 2018 Jul 1;36(19):1949-1956. doi: 10.1200/JCO.2017.75.0158. Epub 2018 May 9.

27.
28.

Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.

Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, Davis ID, Ackermann U, Pathmaraj K, Schuit RC, Windhorst AD, Chua S, Weber WA, Larson SM, Scher HI, Lammertsma AA, Hoekstra OS, Morris MJ.

J Nucl Med. 2018 Oct;59(10):1516-1523. doi: 10.2967/jnumed.117.206490. Epub 2018 Apr 6.

29.

Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents Against Clinically Relevant Gram-Positive and Gram-Negative Pathogens.

Vega SC, Martínez DA, Chalá MDS, Vargas HA, Rosas JE.

Front Microbiol. 2018 Mar 2;9:329. doi: 10.3389/fmicb.2018.00329. eCollection 2018.

30.

CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.

Nougaret S, Lakhman Y, Molinari N, Feier D, Scelzo C, Vargas HA, Sosa RE, Hricak H, Soslow RA, Grisham RN, Sala E.

AJR Am J Roentgenol. 2018 Apr;210(4):918-926. doi: 10.2214/AJR.17.18254. Epub 2018 Feb 28.

31.

Genetic divergence of isolated populations of the native micromoth Bucculatrix mirnae (Lepidoptera: Bucculatricidae) in the arid environments of Northern Chile.

Vargas-Ortiz M, Bobadilla D, Huanca-Mamani W, Vargas HA.

Mitochondrial DNA A DNA Mapp Seq Anal. 2018 Dec;29(8):1139-1147. doi: 10.1080/24701394.2017.1419215. Epub 2017 Dec 22.

PMID:
29272986
32.

Prostate cancer in 2017: Advances in imaging.

Wibmer AG, Vargas HA, Hricak H.

Nat Rev Urol. 2018 Feb;15(2):81-82. doi: 10.1038/nrurol.2017.210. Epub 2017 Dec 12. No abstract available.

33.

Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

McEvoy SH, Nougaret S, Abu-Rustum NR, Vargas HA, Sadowski EA, Menias CO, Shitano F, Fujii S, Sosa RE, Escalon JG, Sala E, Lakhman Y.

Abdom Radiol (NY). 2017 Dec;42(12):2966-2973. doi: 10.1007/s00261-017-1205-5.

PMID:
29128990
34.

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.

Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, Weber WA, Scher HI, Morris MJ, Larson SM.

JAMA Oncol. 2018 Feb 1;4(2):217-224. doi: 10.1001/jamaoncol.2017.3588.

35.

Drug development for noncastrate prostate cancer in a changed therapeutic landscape.

Teo MY, O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Nat Rev Clin Oncol. 2018 Mar;15(3):150. doi: 10.1038/nrclinonc.2017.177. Epub 2017 Nov 8.

PMID:
29115302
36.

Drug development for noncastrate prostate cancer in a changed therapeutic landscape.

Teo MY, O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Nat Rev Clin Oncol. 2018 Mar;15(3):168-182. doi: 10.1038/nrclinonc.2017.160. Epub 2017 Oct 17. Review. Erratum in: Nat Rev Clin Oncol. 2017 Nov 08;:.

37.

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.

Jiménez-Sánchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, Gill MB, Park KJ, Zivanovic O, Konner J, Ricca J, Zamarin D, Walther T, Aghajanian C, Wolchok JD, Sala E, Merghoub T, Snyder A, Miller ML.

Cell. 2017 Aug 24;170(5):927-938.e20. doi: 10.1016/j.cell.2017.07.025.

38.

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.

Abida W, Armenia J, Gopalan A, Brennan R, Walsh M, Barron D, Danila D, Rathkopf D, Morris M, Slovin S, McLaughlin B, Curtis K, Hyman DM, Durack JC, Solomon SB, Arcila ME, Zehir A, Syed A, Gao J, Chakravarty D, Vargas HA, Robson ME, Joseph V, Offit K, Donoghue MTA, Abeshouse AA, Kundra R, Heins ZJ, Penson AV, Harris C, Taylor BS, Ladanyi M, Mandelker D, Zhang L, Reuter VE, Kantoff PW, Solit DB, Berger MF, Sawyers CL, Schultz N, Scher HI.

JCO Precis Oncol. 2017 Jul;2017. doi: 10.1200/PO.17.00029. Epub 2017 May 31.

39.

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.

Scher HI, Graf RP, Schreiber NA, McLaughlin B, Jendrisak A, Wang Y, Lee J, Greene S, Krupa R, Lu D, Bamford P, Louw JE, Dugan L, Vargas HA, Fleisher M, Landers M, Heller G, Dittamore R.

Cancer Res. 2017 Oct 15;77(20):5687-5698. doi: 10.1158/0008-5472.CAN-17-1353. Epub 2017 Aug 17.

40.

Rationale for Modernising Imaging in Advanced Prostate Cancer.

Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, Sala E, Fanti S, Vargas HA, Petralia G, Schlemmer HP, Tombal B, de Bono J.

Eur Urol Focus. 2017 Apr;3(2-3):223-239. doi: 10.1016/j.euf.2016.06.018. Epub 2016 Jul 15. Review.

41.

From Staging to Prognostication: Achievements and Challenges of MR Imaging in the Assessment of Endometrial Cancer.

Nougaret S, Lakhman Y, Vargas HA, Colombo PE, Fujii S, Reinhold C, Sala E.

Magn Reson Imaging Clin N Am. 2017 Aug;25(3):611-633. doi: 10.1016/j.mric.2017.03.010. Epub 2017 May 27. Review.

PMID:
28668163
42.

Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

Vargas HA, Huang EP, Lakhman Y, Ippolito JE, Bhosale P, Mellnick V, Shinagare AB, Anello M, Kirby J, Fevrier-Sullivan B, Freymann J, Jaffe CC, Sala E.

Radiology. 2017 Nov;285(2):482-492. doi: 10.1148/radiol.2017161870. Epub 2017 Jun 22.

43.

Causes of Avascular Hypoechoic Testicular Lesions Detected at Scrotal Ultrasound: Can They Be Considered Benign?

Ma W, Sarasohn D, Zheng J, Vargas HA, Bach A.

AJR Am J Roentgenol. 2017 Jul;209(1):110-115. doi: 10.2214/AJR.16.17333.

PMID:
28639925
44.

High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

Nougaret S, Lakhman Y, Gönen M, Goldman DA, Miccò M, D'Anastasi M, Johnson SA, Juluru K, Arnold AG, Sosa RE, Soslow RA, Vargas HA, Hricak H, Kauff ND, Sala E.

Radiology. 2017 Nov;285(2):472-481. doi: 10.1148/radiol.2017161697. Epub 2017 Jun 16.

45.

Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

McEvoy SH, Nougaret S, Abu-Rustum NR, Vargas HA, Sadowski EA, Menias CO, Shitano F, Fujii S, Sosa RE, Escalon JG, Sala E, Lakhman Y.

Abdom Radiol (NY). 2017 Oct;42(10):2488-2512. doi: 10.1007/s00261-017-1179-3. Review. Erratum in: Abdom Radiol (NY). 2017 Nov 11;:.

46.

Lioptilodes friasi (Lepidoptera: Pterophoridae) Niche Breadth in the Chilean Mediterranean Matorral Biome: Trophic and Altitudinal Dimensions.

Vargas HA, Rasmann S, Ramirez-Verdugo P, Villagra CA.

Neotrop Entomol. 2018 Feb;47(1):62-68. doi: 10.1007/s13744-017-0514-2. Epub 2017 Apr 6.

PMID:
28386773
47.

Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.

Barth BK, De Visschere PJL, Cornelius A, Nicolau C, Vargas HA, Eberli D, Donati OF.

Radiology. 2017 Sep;284(3):725-736. doi: 10.1148/radiol.2017162020. Epub 2017 Mar 27.

48.

A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.

Vargas HA, Veeraraghavan H, Micco M, Nougaret S, Lakhman Y, Meier AA, Sosa R, Soslow RA, Levine DA, Weigelt B, Aghajanian C, Hricak H, Deasy J, Snyder A, Sala E.

Eur Radiol. 2017 Sep;27(9):3991-4001. doi: 10.1007/s00330-017-4779-y. Epub 2017 Mar 13.

49.

Author Reply.

O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Urology. 2017 Apr;102:172. doi: 10.1016/j.urology.2016.10.046. Epub 2017 Mar 6. No abstract available.

PMID:
28279479
50.

The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.

Nougaret S, Robertson N, Golia Pernicka J, Molinari N, Hötker AM, Ehdaie B, Sala E, Hricak H, Vargas HA.

Abdom Radiol (NY). 2017 Jul;42(7):1968-1974. doi: 10.1007/s00261-017-1086-7.

Supplemental Content

Loading ...
Support Center